Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.8K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Epigenetic Regulation01:37

Epigenetic Regulation

3.2K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.2K
Epigenetic Regulation01:46

Epigenetic Regulation

31.7K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.7K
Master Transcription Regulators02:23

Master Transcription Regulators

7.3K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SETDB1-mediated repression of RhoB promotes EMT and metastatic progression in prostate cancer.

Oncogene·2026
Same author

Dual Targeting of Nucleotidase-Dependent and -Independent Functions via PROTAC-Mediated CD73 Degradation.

Journal of medicinal chemistry·2026
Same author

Development of a Direct-to-Biology Platform to Discover Potent MNK Inhibitors.

Journal of medicinal chemistry·2026
Same author

FOXA1 loss drives basal/squamous de-differentiation of prostate cancer and induces an immunosuppressive tumor microenvironment.

Nature communications·2026
Same author

A bivalent lysine-acetylated small-molecule binding site in MYC.

bioRxiv : the preprint server for biology·2026
Same author

Development of DOT1L-Targeted Protein Degraders for Treating MLL-r Leukemia.

Journal of medicinal chemistry·2026

Related Experiment Video

Updated: Oct 25, 2025

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
10:26

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Published on: January 16, 2015

8.6K

Going beyond Polycomb: EZH2 functions in prostate cancer.

Su H Park1, Ka-Wing Fong1,2, Ezinne Mong1

  • 1Division of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Oncogene
|August 5, 2021
PubMed
Summary

Enhancer of Zeste Homolog 2 (EZH2) is crucial in epigenetics and cancer. This review explores EZH2

More Related Videos

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

12.6K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.8K

Related Experiment Videos

Last Updated: Oct 25, 2025

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
10:26

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Published on: January 16, 2015

8.6K
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

12.6K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.8K

Area of Science:

  • Epigenetics and Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • Enhancer of Zeste Homolog 2 (EZH2) is a key component of Polycomb Repressive Complex 2 (PRC2), mediating histone 3 lysine 27 (H3K27) methylation.
  • EZH2 dysregulation is implicated in various cancers, notably prostate cancer, and is upregulated in neuroendocrine prostate cancers.
  • Limited efficacy of current EZH2 inhibitors necessitates a deeper understanding of its multifaceted roles.

Purpose of the Study:

  • To review the regulation of EZH2's canonical histone methyltransferase (MTase) activity and PRC2 recruitment.
  • To explore non-histone substrates and post-translational modifications of EZH2.
  • To summarize non-canonical functions of EZH2 and discuss therapeutic targeting strategies for prostate cancer.

Main Methods:

  • Literature review of EZH2's canonical and non-canonical functions.
  • Analysis of EZH2 regulation, PRC2 recruitment, and non-histone substrates.
  • Discussion of therapeutic prospects based on EZH2's diverse roles.

Main Results:

  • Canonical EZH2 functions involve H3K27 methylation and epigenetic silencing.
  • EZH2 interacts with non-histone substrates and is regulated by post-translational modifications.
  • Non-canonical functions include roles as a transcriptional cofactor, independent of its MTase activity.

Conclusions:

  • EZH2 possesses diverse functions beyond histone methylation, including non-canonical roles.
  • Understanding these varied functions is critical for developing effective therapeutic strategies.
  • Targeting EZH2 offers potential for novel prostate cancer treatments.